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Abstract
Introduction: Currently available recommendations regarding fasting requirements before phlebotomy do not specify any maximum water intake 
volume permitted during the fasting period. The aim was to study the effects of 300 mL water intake 1 h before phlebotomy on specific analytes. 
Materials and methods: Blood was collected from 20 women (median age (min-max): 24 (22 - 50) years) in basal state (T0) and 1 h after 300 mL 
water intake (T1). Glucose, total proteins (TP), urea, creatinine, cystatin C, total bilirubin (BT), total cholesterol, high-density lipoprotein choleste-
rol, low-density lipoprotein cholesterol, triglycerides (Tg), uric acid (UA), high-sensitivity C-reactive protein, gamma-glutamyl transferase (GGT), 
aspartate-aminotransferase (AST), alanine-aminotransferase and lactate-dehydrogenase (LD) were studied. Results were analyzed using Wilcoxon 
test. Mean difference (%) was calculated for each analyte and was further compared with reference change value (RCV). Only mean differences (%) 
higher than RCV were considered clinically significant. 
Results: Significant differences (median T0 vs median T1, P) were observed for TP (73 vs 74 g/L, 0.001); urea (4.08 vs 4.16 mmol/L, 0.010); BT (12 
vs 13 µmol/L, 0.021); total cholesterol (4.9 vs 4.9 mmol/L, 0.042); Tg (1.05 vs 1.06 mmol/L, 0.002); UA (260 vs 270 µmol/L, 0.006); GGT (12 vs 12 
U/L, 0.046); AST (22 vs 24 U/L, 0.001); and LD (364 vs 386 U/L, 0.001). Although the differences observed were statistically significant, they were not 
indicative of clinically significant changes. 
Conclusions: A water intake of 300 mL 1 h prior to phlebotomy does not interfere with the analytes studied in the present work.
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Introduction
Reliability of laboratory results must be guaran-
teed through quality policies all along the bio-
chemical process, including the pre-analytical 
phase, because of the fact that several medical de-
cisions and procedures depend on them (1).
Although the pre-analytical phase is the most ex-
posed to the risk of making mistakes in the labora-
tory, the importance of this phase is often under-
estimated and therefore its impact on results ob-
tained is either unknown or minimized (2). Both 
the organization and management of the labora-
tory personnel involved in these procedures are 
therefore crucial because each stage of the bio-
chemical process is subjected to variability (3). A 
critical issue that has been considered as an im-
portant source of error but is nonetheless essential 
in obtaining reliable results ensuring safety is pa-
tient preparation (4). Several studies have demon-
strated that patients go to the laboratory for blood 
sample collection without adequate preparation. 
This is attributed to the fact that they lack informa-
tion regarding the pre-analytical requirements for 
routine blood tests as well as to the absence of 
harmonization among laboratories (5-8). These 
two factors are indicative of the need for standard-
ized, updated and evidence-based recommenda-
tions for patient preparation to minimize patient 
risks (8).
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Previous research on the changes that biochemi-
cal and haematological markers undergo in re-
sponse to postprandial state emphasizes the need 
for fasting prior to routine blood tests (9,10). How-
ever, fasting is considered either unnecessary or 
optional by some laboratories (11).
Within this context, the Working Group on Preana-
lytical Phase (WG-PRE) of the European Federation 
of Clinical Chemistry and Laboratory Medicine 
(EFLM) issued recommendations for patient prepa-
ration prior to blood sample collection for routine 
biochemical practices; namely to collect blood 
samples between 7 and 9 a.m. after a 12 h fasting 
period during which water intake is allowed, not 
to drink alcohol 24 hours before blood collection, 
and neither to smoke nor to drink caffeine-con-
taining beverages during the morning of blood 
collection (12). Still, no specific recommendation 
on the maximum water volume intake allowed be-
fore blood collection has been issued to date, ex-
cept that habitual water intake is permitted.
A recent consensus study has proposed that fast-
ing is not necessary for the determination of the 
lipid profile (13). This recommendation was based 
on findings from several prospective studies re-
vealing that whereas no changes were observed in 
high-density lipoprotein cholesterol (HDL) con-
centrations in response to a standard regular meal, 
plasma triglycerides (Tg) were found to slightly in-
crease and total cholesterol and low-density lipo-
protein cholesterol (LDL) values were observed to 
decrease although all these variations appeared to 
be clinically non-significant (13). The decrease in 
LDL values observed was attributed to the dilution 
effect derived from fluid-free intake. Still, a de-
crease in LDL in non-fasting individuals may lead 
to errors in the classification of cardiovascular risk 
and therefore in the indication of initiation of lipid-
lowering therapy or in the evaluation of the chang-
es that may occur during this therapy (14). In view 
of this, it is mandatory to study the effect and im-
pact of water intake as a pre-analytical variable on 
routine biochemical laboratory tests.
Our hypothesis is that water intake during fasting 
may affect some laboratory parameters. The pur-
pose of the present work is therefore to study the 
influence of a 300 mL water intake, which is equiv-
alent to a glass of water, during fasting and 1 h be-
fore blood collection may have on some routine 
biochemical tests.
Materials and methods 
Study design
This is an experimental longitudinal study carried 
out in a non-accredited laboratory (according to 
ISO 15189 regulations) at Hospital Municipal de 
Agudos “Dr. Leónidas Lucero” in Bahía Blanca city, 
province of Buenos Aires, Republic of Argentina, in 
October 2016. This study was conducted following 
the methodology previously published by differ-
ent research groups (9,10,15).
Subjects
The study population was composed of 20 female 
students of Biochemistry from the Universidad Na-
cional del Sur, Bahía Blanca, Argentina, who volun-
tarily agreed to participate in this study. Median 
age of volunteers was 24 (min-max: 22-50) years. 
All participants were informed of the aims of the 
present study. They stated that they had no health 
problems and that they were not taking any medi-
cation. They expressed their written consent. This 
study was approved by the Bioethics Committee 
of the above-mentioned hospital. Inclusion criteria 
were absence of chronic or acute pathologies. Ex-
clusion criteria were medication treatment or 
physical activity 24 h before phlebotomy.
Blood sampling
Blood samples for biochemical determinations in 
the basal state were collected on the same day, af-
ter nocturnal rest including a 12 h fasting period 
without water intake. The procedure applied was 
performed by a laboratory technician following the 
guidelines issued by the Clinical and Laboratory 
Standards Institute/National Committee for Clinical 
Laboratory Standards (CLSI/NCCLS) H03-A6 with 
adaptations suggested by Lima-Oliveira et al. (16,17). 
The first blood collection was performed at 9 a.m. 
following WG-PRE/EFLM recommendations, after 
the subjects had remained sitting for 15 minutes 
(12). Immediately after phlebotomy, volunteers 
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drank a glass of water (300 mL) and remained sit-
ting in the blood collection room for an extra hour, 
after which the second blood collection was carried 
out. Two blood samples (5 mL each) were thus ob-
tained per individual: a basal one (T0) and another 
one 1 hour after water intake (T1).
Samples were collected via antecubital vein punc-
ture using needles 21Gx1 (NEOJET, Zhejiang Ou-
gian Medical Apparatus Co, Wenzhou, China) and 
syringes of 10 mL (Hongda, Jiangxi Hongda Medi-
cal Equipment Group Ltd., Nanchang, China). After 
collection, blood samples were distributed in 2.5 
mL plastic tubes with lithium heparin additive 
(TECNON, Laboratorios Argentinos, Berisso, Argen-
tina) and centrifuged at 1500xg for 15 minutes at 
room temperature.
Plasma was separated from packed red blood cells 
within the first 15 minutes after blood collection 
and immediately aliquoted in two polypropylene 
tubes with no additives (TECNON, Laboratorios Ar-
gentinos, Berisso, Argentina) for further analysis in 
different analysers. Blood samples were free from 
haemolysis or lipemia, as confirmed by the haemol-
ysis and lipemia index evaluated in Vitros 4600.
Intake water was table water bottled by a local 
company (Aristu Hnos, Bahía Blanca, Argentina). It 
had been previously subjected to reverse osmosis, 
filtrated, ionized and ozonised to guarantee physi-
cal, chemical and biological quality for human 
consumption. Table 1 shows the chemical compo-
sition of the water used in our study provided by 
the manufacturer. 
Biochemical tests
The analytes studied were: glucose (Glc), total pro-
teins (TP), urea, creatinine (CREA), cystatin C, total 
bilirubin (BT), total cholesterol, HDL, LDL, Tg, uric 
acid (UA), high-sensitivity C-reactive protein 
(hsCRP), gamma-glutamyltransferase (GGT), aspar-
tate-aminotransferase (AST), alanine-aminotrans-
ferase (ALT) and lactate-dehydrogenase (LD).
Biochemical determinations were performed by 
the Vitros® 4600 autoanalyser (Ortho Clinical Diag-
nostics, New Jersey, USA) with proprietary rea-
gents and calibrators. Internal and external quality 
controls were included as part of the standard pro-
cedure. Measurements of the analytes cystatin C, 
hsCRP and LDL were performed using a Modular 
P800® analyser (Roche Diagnostics, Mannheim, 
Germany) following the same quality specifica-
tions. In both cases, determinations were made at 
the same time, which ensured the use of the same 
reagent lot, thus avoiding lot-to-lot variability. The 
analytical coefficient of variation (CVA) for each an-
alyte was obtained using third party control mate-
rial (BIORAD, Irvine, USA). Table 2 lists the analytes 
studied and the methods followed for their deter-
mination.
Statistical analysis 
As the number of individuals studied was lower 
than 30, data were processed using non-paramet-
ric statistics (18). Comparison of medians between 
T0 and T1 was made with the non-parametric Wil-
coxon Signed Rank Test for paired samples. Statis-
tical significance was set at P < 0.05. Statistical 
Package for Social Science for Windows (SPSS) 
Analyte Method Concentration
Sulphate SM 4500 SO4-E (turbidimetric) 8 mg/L
Fluoride SM 4500 FD (colorimetric 
SPADNS)
0.16 mg/L
Nitrate SM 4500 NO3 E (cadmium 
reduction manual)
6.1 mg/L
Nitrite SM 4500 NO2 B 
(spectrophotometric manual)
0.039 mg/L
Ammonia SM 4500 NH3 C (titration) < 0.1 mg/L
Chloride SM 4500 Cl B (titrimetric silver 
nitrate)
0.840 mmol/L
Calcium SM 3500 Ca D (titrimetric 
EDTA)
0.050 mmol/l
Sodium Ion Selective Electrode 0.003 mmol/L
Magnesium SM 3500 Mg E (colorimetric) 0.070 mmol/L
Iron SM 3500 Fe D (colorimetric) 0.01 mg/L
Arsenic SM 3500 As D (colorimetric) < 0.005 mg/L
SM - standard methods for water & wastewater examination; 
available at http://www.standardmethods.org (35). 
Table 1. Chemical composition of water provided by the manu-
facturer
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software (Version 15.0. Chicago, IL, USA) was used 
for data analysis.
The clinically significant change was calculated for 
each analyte using the reference change value 
(RCV) equation as follows (15,19-21):
RCV =    2  Z  CVA + CVI 
2 2
where Z is a constant for the level of statistical con-
fidence (1.96 for α = 0.05), CVI is the within-subject 
biological variation obtained from Westgard data-
base, and CVA is the analytical coefficient of varia-
tion from the laboratory internal quality control 
(22). All these data are included in Table 3.
For each volunteer, the mean difference (%) of 
each analyte was calculated using the following 
formula (23-27):




From these data, the mean value of the mean dif-
ference (MD, %) of each analyte was obtained and 
further compared with the corresponding RCV. A 
clinically significant difference was considered per 
analyte when MD (%) was higher than the respec-
tive RCV. For analytes with MD (%) higher than the 
desirable specification for imprecision (DSI) de-
rived from biological variation, a graphical repre-
sentation of the change or interference detected 
(interferogram) was created and expressed as MD 
(%) with respect to RCV (22,28). 
Results
Table 3 shows results from the present work, ex-
pressed as the median and interquartile range. Af-
ter a 300 mL water intake 1 h before phlebotomy, 
significantly higher values (T0 median vs T1 medi-
an, P) were observed for urea (4.08 vs 4.16 mmol/L; 
0.010), BT (12 vs 13 µmol/L; 0.021), total cholesterol 
(4.9 vs 4.9 mmol/L; 0.042), Tg (1.05 vs 1.06 mmol/L; 
0.002), UA (260 vs 270 µmol/L; 0.006), and GGT (12 
vs 12 U/L; 0.046). 
As shown in Table 3 and Figure 1, after water in-
take significantly higher TP concentrations (73 vs 
74 g/L; 0.001), AST (22 vs 24 U/L; 0.001) and LD ac-
tivities (364 vs 386 U/L; 0.001) were observed. Still, 
unlike the previous cases, MDs (%) of these ana-
lytes exceeded their DSI (MD (%) vs DSI: 2.2 vs 
1.4%; 9.2 vs 6.2%, and 5.3 vs 4.3%, respectively). 
Nonetheless, the comparison of MDs (%) with RCV 
showed that no clinically relevant changes oc-
curred in the analytes studied.
Discussion
Our results demonstrate that a 300 mL water in-
take 1 h before phlebotomy produces no clinically 
significant changes in the series of analytes as-
sessed in our study.
Analyte (unit) Method
Glc (mmol/L) Enzymatic/colorimetric-MicroSlide Technology
TP (g/L) Colorimetric-MicroSlide Technology
Urea (mmol/L) Enzymatic/colorimetric-MicroSlide Technology
CREA (µmol/L) Enzymatic-MicroSlide Technology
Cystatin C (mg/L) Turbidimetric immunoassay





HDL (mmol/L) Direct assay-MicroSlide Technology
LDL (mmol/L) Direct assay
Tg (mmol/L) Enzymatic/colorimetric-MicroSlide Technology
UA (µmol/L) Enzymatic/colorimetric-MicroSlide Technology
hsCRP (mg/L) Turbidimetric immunoassay
GGT (U/L 37 °C) Kinetic/UV-Microslide Technology
AST (U/L 37 °C) Kinetic/colorimetric-MicroSlide Technology
ALT (U/L 37 °C) Kinetic/UV-MicroSlide Technology
LD (U/L 37 °C) Kinetic/UV-MicroSlide Technology
Glc - glucose. TP - total proteins. CREA - creatinine. BT - total 
bilirubin. HDL - high-density lipoprotein cholesterol. LDL - 
low-density lipoprotein cholesterol. Tg - triglycerides. UA - uric 
acid. hsCRP - high-sensitivity C-reactive protein. GGT - gam-
ma-glutamyltransferase. AST - aspartate-aminotransferase. 
ALT - alanine-aminotransferase. LD – lactate-dehydrogenase.
Table 2. Laboratory tests performed with corresponding meth-
ods
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(%) Basal values (T0)
Values 1 h after 
water intake (T1)
P Mean difference (%)
RCV 
(%)
Glc (mmol/L) 1.4 4.5 2.3 4.8 (4.5-5.1) 4.9 (4.6-5.3) 0.104 1.5 13.0
TP (g/L) 0.9 2.8 1.4 73 (70-75) 74 (72-77) 0.001 2.2* 8.0
Urea (mmol/L) 3.0 12.1 6.1 4.08 (3.38-4.75) 4.16 (3.41-5.04) 0.010 2.9 34.6
CREA (µmol/L) 1.4 6.0 3.0 73.4 (68.9-77.8) 71.6 (66.3-77.8) 0.209 - 1.0 16.9
Cystatin C (mg/L) 0.6 5.5 2.5 0.75 (0.71-0.82) 0.75 (0.72-0.79) 0.375 - 1.1 15.3
BT (µmol/L) 5.8 21.8 10.9 12 (9-15) 13 (7-15) 0.021 5.2 62.5
Cholesterol, total (mmol/L) 1.8 6.0 3.0 4.9 (4.2-5.3) 4.9 (4.3-5.4) 0.042 1.2 17.2
HDL (mmol/L) 2.8 7.3 3.7 1.8 (1.3-1.9) 1.8 (1.4-2.0) 0.082 1.7 21.7
LDL (mmol/L) 1.6 7.8 3.9 2.6 (2.2-2.9) 2.5 (2.2-2.9) 0.129 - 1.3 22.1
Tg (mmol/L) 3.5 19.9 10.0 1.05 (0.79-1.62) 1.06 (0.75-1.43) 0.002 - 6.5 56.0
UA (µmol/L) 3.2 8.6 4.3 260 (220-290) 270 (220-290) 0.006 2.2 25.4
hsCRP (mg/L) 1.3 42.2 21.1 1.00 (0.42-2.27) 1.02 (0.42-2.13) 0.070 - 1.7 117.0
GGT (U/L 37 °C) 1.5 13.4 6.7 12 (10-17) 12 (10-18) 0.046 2.6 37.4 
AST (U/L 37 °C) 5.5 12.3 6.2 22 (20-26) 24 (22-32) 0.001 9.2* 37.3 
ALT (U/L 37 °C) 6.0 19.4 9.7 16 (13-22) 17 (12-22) 0.418 3.5 56.3 
LD (U/L 37 °C) 3.6 8.6 4.3 364 (342- 394) 386 (364-418) 0.001 5.3* 25.8 
Results are shown as median and interquartile range. P < 0.05 was considered statistically significant. *Mean difference (%) higher 
than DSI. CVA - analytical coefficient of variation. CVI - within-subject biological variation. DSI - desirable specification for imprecision 
derived from biological variation. T0 - basal; T1 - 1 h after 300 mL water intake. RCV - reference change value. Glc - glucose. TP 
- total proteins. CREA - creatinine. BT - bilirubin, total. HDL - high-density lipoprotein cholesterol. LDL - low-density lipoprotein 
cholesterol. Tg - triglycerides. UA - uric acid. hsCRP - high-sensitivity C-reactive protein. GGT - gamma-glutamyltransferase. AST - 
aspartate-aminotransferase. ALT - alanine-aminotransferase. LD – lactate-dehydrogenase.
Figure 1. Water intake interferograms for total proteins, aspartate aminotransferase and lactate dehydrogenase. T0 - basal; T1 - 1 h af-
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Given the importance that reliable laboratory re-
sults have in medical decision-makings, instruc-
tions on fasting must be clearly and concisely giv-
en to patients to ensure sample quality. According 
to the general recommendations published in 
2014 on the harmonization of water intake, water 
intake is permitted before phlebotomy, i.e. during 
fasting hours (12). However, little is known not only 
on how much water should be permitted but also 
on the effects of specific water intake volumes on 
laboratory parameters during fasting. In our study, 
an intake of a specific volume of water rather than 
a “habitual” or an “ad libitum” water intake was 
considered. The volume chosen was 300 mL which 
is equivalent to a regular glass of water that any 
patient may drink before phlebotomy.
Water absorption is a very rapid process. A recent 
study has shown that water appears in plasma and 
blood cells as soon as 5 min after water intake (29). 
Torsdottir and Andersson demonstrated that a 
300 mL water intake along with food after a 12 h 
fasting period increases blood Glc and insulin con-
centrations in healthy subjects, and only Glc in 
well-controlled diabetic patients (30). In our study, 
no significant changes were observed in Glc con-
centrations in the fasting state 1 h after intake of 
the same amount of water, thus suggesting that 
only concurrent food and water intake may influ-
ence Glc concentrations.
Furthermore, previous research conducted on in-
dividuals without previous fasting detected a de-
crease in LDL after food intake (31). The authors of 
this study attributed this decrease to a haemodilu-
tion effect caused by the liquids ingested. In con-
trast, our study showed that a 300 mL water intake 
1 h prior to phlebotomy did not change LDL con-
centrations. 
Several of the analytes studied in the present work 
were observed to undergo statistically significant 
changes. Special attention was paid to the differ-
ences observed in TP, AST and LD, which were 
higher than the DSI. In view of the need to evalu-
ate the clinical relevance of such changes, both an-
alytical and biological variability were taken into 
account. Our estimation of RCV, a reference point 
considered to be a more statistically structured ap-
proach than DSI for the determination of clinically 
relevant changes, revealed that none of the ana-
lytes studied underwent relevant changes (15,32).
Our findings clearly indicate the importance of ob-
jectively assessing the clinical significance of the 
statistically significant changes that may occur in 
an analyte concentration as a consequence of pre-
analytical variability. That is, if differences are in-
deed recorded, to what extent are these differenc-
es relevant (33,34)? Decision makings based exclu-
sively on the interpretation of the P value for the 
harmonization of patient preparation prior to 
phlebotomy may lead to erroneous conclusions.
A limitation of our study was the low number of 
participants as well as gender- and age-bias. 
Therefore, further research on a larger population 
will allow confirming the results derived from our 
small population-based study. In addition, taking 
into account that volunteers in the present study 
drank only 300 mL of water after a 12 h fasting pe-
riod, it will be useful to investigate the influence of 
different water volume intakes during fasting on 
laboratory measurements to accurately determine 
the maximum water intake volume permitted dur-
ing fasting.
The WG-PRE/EFLM states that although it is impor-
tant to know the maximum volume of water in-
take permitted before phlebotomy, there is still no 
evidence recommending a specific water intake 
volume (12). In this sense, our finding showing that 
the ingestion of a regular glass of water 1 h before 
phlebotomy is accompanied by no clinically signif-
icant changes is therefore an important contribu-
tion to future research aiming at determining the 
water volume that could be permitted prior to 
some other clinical biochemical determinations. 
Based on our results, it can be concluded that a 
300 mL water intake 1 h prior to phlebotomy does 
not interfere in the analytes studied in the present 
work. This is the first study carried out on the ef-
fect of water intake during fasting hours on some 
biochemical determinations. 
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